Yezhen Tan
Beijing, 100101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The extracellular-matrix-remodeling capability exposes therapeutic vulnerability in a subset of renal cell carcinomas with tumor thrombi.
Journal: Developmental cell
Published: June 22, 2024
UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA.
Journal: EBioMedicine
Published: September 26, 2022
Single-cell atlases link macrophages and CD8+ T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma.
Journal: Theranostics
Published: July 19, 2022
Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways.
Journal: Clinical epigenetics
Published: May 20, 2022
DNA methylation subtypes guiding prognostic assessment and linking to responses the DNA methyltransferase inhibitor SGI-110 in urothelial carcinoma.
Journal: BMC medicine
Published: February 08, 2022
Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer.
Journal: Frontiers in immunology
Published: September 25, 2021
Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing.
Journal: Genome biology
Published: July 19, 2021
Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma.
Journal: Frontiers in cell and developmental biology
Published: May 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026